[vc_row][vc_column width=”1/5″]
Prof. Edoardo Spina, Italy
COUNCILLOR
[/vc_column]
[vc_column width=”4/5″]
Edoardo Spina graduated in Medicine at the University of Messina in 1981 with full marks and honor. He became specialist in Neurology (1985) and Psychiatry (1991) at the same university. From 1983 to 1987 he was visiting scientist at the Department of Clinical Pharmacology, Huddinge University Hospital at Karolinska Institute, Stockholm, Sweden, where in January 1987 he took the Ph D in Clinical Pharmacology.
From January to March 1987 he was visiting professor at the Department of Pharmacology and Psychiatry, University of Extremadura, Badajoz, Spain. From 1992 contract professor at the school of specialisation in Pharmacology at Messina University. In November 1998 he became associate professor of Pharmacology at Institute of Pharmacology, University of Messina. In June 2005 he was appointed as full professor of Pharmacology at the Department of Clinical and Experimental Medicine and Pharmacology. From 2009 to 2012 vice dean of the Faculty of Medicine at the University of Messina. At present he is head of the school of specialisation in Pharmacology, co-ordinator of the PhD course in Clinical and Experimental Biomedical Sciences at the University of Messina, and President of the Ethics Committee of the area of Messina.
His main scientific interest are clinical neuropsychopharmacology and drug metabolism. In particular, he has been involved in studies on the pharmacokinetics and drug interactions of antidepressants, antipsychotics and mood stabilizers, on the implications of pharmacogenetics in psychiatry and on the role of therapeutic drug monitoring of psychotropic drugs. Author of about 200 articles in international journals, 20 chapters in scientific books, and editor of 1 book. He has participated and lectured in more than 100 international scientific meetings. He has been principal investigator in many international (EU), national and regional research projects Member of several scientific societies, at present he is in the Executive Committee of the European Association for Clinical Pharmacology and Therapeutics. Associate Editor of Frontiers in Pharmacogenetics, member of the editorial board of Therapeutic Drug Monitoring and Basic & Clinical Pharmacology & Toxicology and referee for some of the most important journals in the field of clinical neuropsychopharmacology
[/vc_column][/vc_row]